Keyphrases
Intraclass Correlation Coefficient
100%
Serologic
100%
Multiplex Assay
100%
Inflammatory Biomarkers
100%
Intra-individual Variation
100%
Assay Reliability
100%
Chemokines
75%
Person Correlation
50%
CXCL8
50%
HIV Patients
25%
Granulocyte Colony-stimulating Factor (G-CSF)
25%
Interleukin-10
25%
IL-12p70
25%
Interleukin-2
25%
CCL11
25%
CCL13
25%
Chemokine (C-C motif) Ligand 2 (CCL2)
25%
Interleukin-6
25%
CXCL10
25%
Epidemiologic Studies
25%
Biomarker Testing
25%
Age-adjusted
25%
Linear Mixed Model
25%
Soluble interleukin-2 Receptor (sIL-2R)
25%
Epidemiological Research
25%
Luminex
25%
Assay System
25%
Chronic Conditions
25%
Multicenter AIDS Cohort Study
25%
HIV Men
25%
Immune Dysregulation
25%
Soluble CD14 (sCD14)
25%
Carbon Tetrachloride
25%
Intraindividual Variability
25%
Technical Variability
25%
Soluble Receptor
25%
Multiple Platforms
25%
Meso Scale Discovery
25%
CXCL13
25%
Circulating Cytokines
25%
CCL17
25%
SCD27
25%
Sgp130
25%
External Control
25%
Discovery Platforms
25%
Soluble Cytokine Receptor
25%
Immunology and Microbiology
Cytokine
100%
Chemokine
75%
Human Immunodeficiency Virus
50%
Tumor Necrosis Factor
25%
CXCL10
25%
Granulocyte Macrophage Colony-Stimulating Factor
25%
Interleukin-6
25%
CCL2
25%
Cytokine Receptor
25%
Immune Dysregulation
25%
B Cell Activating Factor
25%
CXCL13
25%
CCL17
25%
CCL13
25%
CCL11
25%
Neuroscience
Chemokine
100%
Human Immunodeficiency Virus
66%
CCL13
33%
CCL2
33%
CCL11
33%
B Cell Activating Factor
33%
CXCL10
33%
CXCL13
33%
Granulocyte Macrophage Colony-Stimulating Factor
33%
Cytokine Receptor
33%
CCL17
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Cytokine
50%
Chemokine
37%
HIV
25%
Epidemiology
25%
Inflammation
12%
Cohort Study
12%
Prospective Study
12%
Tumor Necrosis Factor
12%
Granulocyte Macrophage Colony Stimulating Factor
12%
B Cell Activating Factor
12%
Mixed Model
12%
Cytokine Receptor
12%
Immune Dysregulation
12%
Mathematics
correlation coefficient ρ
100%
Intraclass Correlation
100%
Detectability
50%
Linear Mixed Model
25%
Prospective Study
25%